CA2201865A1 - Laminin chains: diagnostic and therapeutic use - Google Patents

Laminin chains: diagnostic and therapeutic use

Info

Publication number
CA2201865A1
CA2201865A1 CA002201865A CA2201865A CA2201865A1 CA 2201865 A1 CA2201865 A1 CA 2201865A1 CA 002201865 A CA002201865 A CA 002201865A CA 2201865 A CA2201865 A CA 2201865A CA 2201865 A1 CA2201865 A1 CA 2201865A1
Authority
CA
Canada
Prior art keywords
diagnostic
therapeutic use
laminin chains
laminin
chains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002201865A
Other languages
French (fr)
Other versions
CA2201865C (en
Inventor
Karl Tryggvason
Pekka Kallunki
Charles Pyke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/317,450 external-priority patent/US5660982A/en
Application filed by Individual filed Critical Individual
Publication of CA2201865A1 publication Critical patent/CA2201865A1/en
Application granted granted Critical
Publication of CA2201865C publication Critical patent/CA2201865C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The instant invention provides for the identification diagnosis, monitoring, and treatment of invasive cells using the laminin 5 gamma-2 chain protein or nucleic acid sequence, or antibodies thereto.
CA002201865A 1994-10-04 1995-10-04 Laminin chains: diagnostic and therapeutic use Expired - Fee Related CA2201865C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/317,450 1994-10-04
US08/317,450 US5660982A (en) 1994-10-04 1994-10-04 Laminin chains: diagnostic uses
PCT/EP1995/003918 WO1996010646A1 (en) 1994-10-04 1995-10-04 Laminin chains: diagnostic and therapeutic use

Publications (2)

Publication Number Publication Date
CA2201865A1 true CA2201865A1 (en) 1996-04-11
CA2201865C CA2201865C (en) 2006-05-23

Family

ID=36481358

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002201865A Expired - Fee Related CA2201865C (en) 1994-10-04 1995-10-04 Laminin chains: diagnostic and therapeutic use

Country Status (1)

Country Link
CA (1) CA2201865C (en)

Also Published As

Publication number Publication date
CA2201865C (en) 2006-05-23

Similar Documents

Publication Publication Date Title
GR3031488T3 (en) Laminin chains: diagnostic and therapeutic use
MXPA02011656A (en) Nrg 2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods.
CA2367955A1 (en) Abc1 polypeptide and methods and reagents for modulating cholesterol levels
CA2381770A1 (en) Human ctla-4 antibodies and their uses
PL319021A1 (en) Body weight modulators, appropriate nucleic acid and proteins and their diagnostic and therapeutic application
WO2002040634A3 (en) Expression miniarrays and uses thereof
EP1783139A3 (en) Human telomerase catalytic subunit
CA2219988A1 (en) Cd16-ii variants
CA2274581A1 (en) Oligonucleotide compositions and methods for the modulation of the expression of b7 protein
WO1997008318A3 (en) Compounds and methods for treatment and diagnosis of prostate cancer
CA2184920A1 (en) Methods of diagnosing and treating preeclampsia
WO1996003502A3 (en) Muc1 derived proteins for the diagnosis, imaging and therapy of human cancer
AU601765B2 (en) Polypeptide useful for the alleviation, treatment and diagnosis of autoimmune diseases, especially arthritic conditions etc.,
EP1734134A3 (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
WO1998026054A3 (en) Pyk2 related products and methods
WO1998059040A3 (en) Human catalytic telomerase sub-unit and its diagnostic and therapeutic use
ITRM930291A0 (en) PROCEDURE FOR THE PREPARATION OF IODINATED BIOPOLYMERS WITH DISINFECTANT AND HEALING ACTIVITY, AND IODINATED BIOPOLYMERS SO OBTAINED.
NO963487L (en) Isolated tyrosinase-derived peptides, and uses thereof
WO1999008667A3 (en) Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
HU906639D0 (en) Diagnostic process for detecting htlv-i peptides and their antibodies causing infection, and vaccine for treating the disease
TR199600588A2 (en) 4-Floralkyl substituted benzoylguanidines, the method for making them, their use as drugs or diagnostic agents, and medicaments containing them.
EP2048235A3 (en) Synthetic Mammalian Alpha-N-Acetylglucosaminidase and Genetic Sequences Encoding Same
WO1998051782A3 (en) Human 3-hydroxyisobutyryl-coenzyme a hydrolase
AU4654097A (en) Rdgb-proteins
AU9334098A (en) Molecular diagnostic of glaucomas associated with chromosomes 1, and method of treatment thereof

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed